• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Bluebird bio inks first Medicaid coverage agreement for sickle cell gene therapy, signing...

cafead

Administrator
Staff member
  • cafead   Mar 11, 2024 at 11:42: AM
via Bluebird bio has secured its first Medicaid outcomes-based agreement for its sickle cell disease gene therapy Lyfgenia (lovo-cel), signing on with the state of Michigan.

article source
 

<